Chimalakonda, Anjaneya, James Burke, Lihong Cheng, Ian Catlett, Aditya Patel, Jun Shen, Ihab Girgis, Subhashis Banerjee, and John Throup. “Selective Inhibition of Tyrosine Kinase 2 With Deucravacitinib (BMS-986165) Compared With Janus Kinase 1−3 Inhibitors”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s108. Accessed May 18, 2022. https://www.jofskin.org/index.php/skin/article/view/1081.